search icon
bntc-img

Benitec biopharma inc. share price

BNTC
NAQ
$8.87
+$0.12
(1.37%)
1D
Industry: Biotechnology Sector: Health Care

Benitec biopharma inc. analyst forecast

Benitec biopharma inc. share price chart

Benitec biopharma inc. key stock metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$305.22M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
73.14K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.25
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$8.52 L
$16.76 H
$8.87

About benitec biopharma inc., common stock

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines in the United States. Its Silence and Replace, a DNA-directedRNA interference platform, that combines RNA interference with gene therapy to create medicines which simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene, which is in phase 1b/2a for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California. more

Industry: BiotechnologySector: Health Care

Benitec biopharma inc. stock returns

Time FrameBNTCSectorS&P500
1-Week Return-1.22%1.19%0.53%
1-Month Return-28.76%0.95%1.49%
3-Month Return-34.2%3.69%2.98%
6-Month Return-19.44%12.61%13.8%
1-Year Return-37.54%16.62%15.26%
3-Year Return191.78%28.9%79.08%
5-Year Return-85.22%33.51%78.02%
10-Year Return-97.57%132.91%258.56%

Benitec biopharma inc. financials

Jun '22Jun '23Jun '24Jun '25Jun '265YR TREND
Total Revenue73.00K75.00K---[{"date":"2022-06-30","value":97.33,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]
Cost of Revenue9.00K-343.00K396.00K481.00K[{"date":"2022-06-30","value":1.87,"profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":71.31,"profit":true},{"date":"2025-06-30","value":82.33,"profit":true},{"date":"2026-06-30","value":100,"profit":true}]
Gross Profit64.00K75.00K(343.00K)(396.00K)(481.00K)[{"date":"2022-06-30","value":85.33,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-457.33,"profit":false},{"date":"2025-06-30","value":-528,"profit":false},{"date":"2026-06-30","value":-641.33,"profit":false}]
Gross Margin87.67%100.00%(Infinity%)(Infinity%)(Infinity%)[{"date":"2022-06-30","value":87.67,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2026-06-30","value":null,"profit":false}]
Operating Expenses17.92M19.16M22.49M41.37M50.71M[{"date":"2022-06-30","value":35.33,"profit":true},{"date":"2023-06-30","value":37.77,"profit":true},{"date":"2024-06-30","value":44.35,"profit":true},{"date":"2025-06-30","value":81.58,"profit":true},{"date":"2026-06-30","value":100,"profit":true}]
Operating Income(17.85M)(19.08M)(22.49M)(41.77M)(51.19M)[{"date":"2022-06-30","value":-1785400000,"profit":false},{"date":"2023-06-30","value":-1908100000,"profit":false},{"date":"2024-06-30","value":-2249000000,"profit":false},{"date":"2025-06-30","value":-4176500000,"profit":false},{"date":"2026-06-30","value":-5119200000,"profit":false}]
Total Non-Operating Income/Expense(386.00K)(514.00K)1.64M7.13M11.21M[{"date":"2022-06-30","value":-3.44,"profit":false},{"date":"2023-06-30","value":-4.58,"profit":false},{"date":"2024-06-30","value":14.65,"profit":true},{"date":"2025-06-30","value":63.61,"profit":true},{"date":"2026-06-30","value":100,"profit":true}]
Pre-Tax Income(18.21M)(19.56M)(21.75M)(37.92M)(45.55M)[{"date":"2022-06-30","value":-1820800000,"profit":false},{"date":"2023-06-30","value":-1956200000,"profit":false},{"date":"2024-06-30","value":-2175100000,"profit":false},{"date":"2025-06-30","value":-3791700000,"profit":false},{"date":"2026-06-30","value":-4554600000,"profit":false}]
Income Taxes-----[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]
Income After Taxes(18.21M)(19.56M)(21.75M)(37.92M)(45.55M)[{"date":"2022-06-30","value":-1820800000,"profit":false},{"date":"2023-06-30","value":-1956200000,"profit":false},{"date":"2024-06-30","value":-2175100000,"profit":false},{"date":"2025-06-30","value":-3791700000,"profit":false},{"date":"2026-06-30","value":-4554600000,"profit":false}]
Income From Continuous Operations(18.21M)(19.56M)(21.75M)(37.92M)(45.55M)[{"date":"2022-06-30","value":-1820800000,"profit":false},{"date":"2023-06-30","value":-1956200000,"profit":false},{"date":"2024-06-30","value":-2175100000,"profit":false},{"date":"2025-06-30","value":-3791700000,"profit":false},{"date":"2026-06-30","value":-4554600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]
Net Income(18.21M)(19.56M)(21.75M)(37.92M)(45.55M)[{"date":"2022-06-30","value":-1820800000,"profit":false},{"date":"2023-06-30","value":-1956200000,"profit":false},{"date":"2024-06-30","value":-2175100000,"profit":false},{"date":"2025-06-30","value":-3791700000,"profit":false},{"date":"2026-06-30","value":-4554600000,"profit":false}]
EPS (Diluted)(19.31)(14.12)(2.68)(1.05)(0.98)[{"date":"2022-06-30","value":-1931,"profit":false},{"date":"2023-06-30","value":-1412,"profit":false},{"date":"2024-06-30","value":-268,"profit":false},{"date":"2025-06-30","value":-105,"profit":false},{"date":"2026-06-30","value":-98,"profit":false}]

Benitec biopharma inc. ratios

Benitec biopharma inc. liquidity ratios

These ratios help you determine the liquidity of the company. Higher is better.

BNTC
Cash Ratio 33.68
Current Ratio 34.00
Quick Ratio 34.00

Benitec biopharma inc. asset efficiency ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BNTC
ROA (LTM) -24.94%
ROE (LTM) -28.41%

Benitec biopharma inc. liability ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BNTC
Debt Ratio Lower is generally better. Negative is bad. 0.03
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.97

Benitec biopharma inc. valuation ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BNTC
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 2.36
Price/FCF NM
EV/R 0.00
EV/Ebitda NM
PEG NM

Faqs

What is Benitec Biopharma Inc. share price today?

Benitec Biopharma Inc. (BNTC) share price today is $8.87

Can Indians buy Benitec Biopharma Inc. shares?

Yes, Indians can buy shares of Benitec Biopharma Inc. (BNTC) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BNTC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Benitec Biopharma Inc. be purchased?

Yes, you can purchase fractional shares of Benitec Biopharma Inc. (BNTC) via the Vested app. You can start investing in Benitec Biopharma Inc. (BNTC) with a minimum investment of $1.

How to invest in Benitec Biopharma Inc. shares from India?

You can invest in shares of Benitec Biopharma Inc. (BNTC) via Vested in three simple steps:

  • Click on Sign Up or Invest in BNTC stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Benitec Biopharma Inc. shares

What is Benitec Biopharma Inc. 52-week high and low stock price?

The 52-week high price of Benitec Biopharma Inc. (BNTC) is $16.76. The 52-week low price of Benitec Biopharma Inc. (BNTC) is $8.52.

What is Benitec Biopharma Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Benitec Biopharma Inc. (BNTC) is

What is Benitec Biopharma Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Benitec Biopharma Inc. (BNTC) is 2.36

What is Benitec Biopharma Inc. dividend yield?

The dividend yield of Benitec Biopharma Inc. (BNTC) is 0.00%

What is the Market Cap of Benitec Biopharma Inc.?

The market capitalization of Benitec Biopharma Inc. (BNTC) is $305.22M

What is Benitec Biopharma Inc.'s stock symbol?

The stock symbol (or ticker) of Benitec Biopharma Inc. is BNTC

How Can Investors Use Benitec Biopharma Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Benitec Biopharma Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Benitec Biopharma Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Benitec Biopharma Inc. shares for Indian investors?

When investing in Benitec Biopharma Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Benitec Biopharma Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Benitec Biopharma Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of Benitec Biopharma Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Benitec Biopharma Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top